Welcome to our dedicated page for DIVERSIFIED HEALTHCARE TRUST SEC filings (Ticker: DHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DIVERSIFIED HEALTHCARE TRUST's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DIVERSIFIED HEALTHCARE TRUST's regulatory disclosures and financial reporting.
Diversified Healthcare Trust filed a current report stating that it has posted a new investor presentation on its website. The presentation, dated February 24, 2026, is included as Exhibit 99.1 and is furnished as part of the disclosure to provide investors with updated information about the company.
Diversified Healthcare Trust files its 2025 annual report outlining a large U.S. healthcare real estate platform focused on senior living, medical office and life science properties. As of December 31, 2025, it owned 298 properties across 33 states and Washington, D.C., plus interests in two joint ventures.
The joint ventures own about 2.2 million rentable square feet that were 99% leased with a 14.2-year average remaining lease term. DHC emphasizes senior housing demand from an aging U.S. population, selective acquisitions and dispositions, development and repositioning, and extensive use of third-party managers under TRS structures, while highlighting significant regulatory, reimbursement, financing and operational risks.
Diversified Healthcare Trust reported a Q4 2025 net loss of $21.2 million, or $0.09 per share, but significantly stronger cash metrics, including normalized FFO of $21.8 million, or $0.09 per share, and Adjusted EBITDAre of $72.4 million. Same property senior housing operating portfolio (SHOP) cash NOI rose 27.6% year over year to $38.3 million, driven by 82.4% occupancy and a 5.8% increase in average monthly rates. The medical office and life science portfolio generated same property cash NOI of $24.1 million with 94.7% occupancy.
For full year 2025, DHC posted a net loss of $285.9 million, impacted by $165.7 million of impairments and high interest expense, while normalized FFO improved to $64.4 million. Management highlighted approximately $6.3 billion of real estate across 298 properties and noted it fully redeemed its zero‑coupon notes due 2026, reducing net debt to annualized Adjusted EBITDAre to 8.1x. The company issued 2026 guidance calling for NOI of $297–$313 million, Adjusted EBITDAre of $290–$305 million, and normalized FFO of $125–$140 million, with expected SHOP NOI growth of 26%–33%.
Diversified Healthcare Trust reported two key items. First, it incurred an incentive management fee of $17.9 million for the 2025 calendar year under its Business Management Agreement with The RMR Group LLC. This fee is payable in cash by January 30, 2026 and will be recorded as an expense in the company’s financial statements for the year ended December 31, 2025.
Second, on January 9, 2026, the company received a cash dividend of $27.2 million from AlerisLife Inc. in connection with AlerisLife’s sale of all assets and wind-down of its business. Diversified Healthcare Trust expects to receive an additional cash dividend of approximately $3.0 million to $7.0 million upon completion of that wind-down, though the amount or timing may change.
Diversified Healthcare Trust reported that its President, CEO and Director Christopher J. Bilotto purchased 20,000 common shares of beneficial interest on 12/15/2025 at a weighted average price of $4.886 per share, in multiple transactions priced between $4.88 and $4.89.
After these purchases, he beneficially owns 266,284.908 DHC shares directly, which includes 385.018 shares acquired through a dividend reinvestment plan since his last Section 16 filing.
Diversified Healthcare Trust reported Q3 2025 results. Total revenues were $388.706 million, led by resident fees and services of $333.390 million and rental income of $55.316 million. The quarter posted a net loss of $164.040 million (−$0.68 per share), reflecting $93.243 million of impairment charges, interest expense of $48.886 million, and an $11.191 million loss on early debt actions.
Year to date, revenue reached $1.158 billion with a net loss of $264.665 million. The company sold 32 properties for $353.675 million, recording gains of $103.971 million, and classified 50 properties as held for sale. Subsequent to quarter-end, 12 more properties were sold for $42.130 million.
DHC refinanced and reduced near-term debt: it redeemed the entire $380 million 9.75% senior notes due June 2025, issued $375 million of 7.25% senior secured notes due 2030, and partially redeemed senior secured notes due 2026, leaving $334.370 million outstanding. Cash and cash equivalents were $201.371 million. Total assets were $4.684 billion and equity was $1.689 billion as of September 30, 2025.
Diversified Healthcare Trust furnished an update on its business by announcing financial results for the quarter ended September 30, 2025. The company provided a summary press release and a detailed earnings presentation to accompany the results, making them available as Exhibits 99.1 and 99.2. This 8‑K is limited to distributing those materials and does not itself include the underlying figures.
Diversified Healthcare Trust filed a current report noting that it has made a new investor presentation available on its website. On October 8, 2025, the company posted this updated presentation, which is also attached to the report as Exhibit 99.1. The presentation is described as an investor communication and is furnished rather than filed, which typically means it is for informational purposes about the business rather than a formal change to financial statements or contracts.
DIVERSIFIED HEALTHCARE TRUST filed an 8-K reporting the execution of an indenture dated September 26, 2025 with U.S. Bank Trust Company, National Association as trustee. The indenture governs the company’s 7.250% Senior Secured Notes due 2030 and names certain subsidiaries as guarantors. The filing includes the form of the indenture and an Inline XBRL cover page.
The report is signed by Matthew C. Brown, Chief Financial Officer and Treasurer, indicating the company completed the documentation for the secured note issuance structure described in the filing.
Matthew C. Brown, the Chief Financial Officer and Treasurer of Diversified Healthcare Trust (ticker DHC), reported a sale of common shares on 09/16/2025. The Form 4 shows 9,711 shares were disposed of at a reported price of $4.37 per share, reducing his beneficial ownership to 113,954 shares. The filing states the disposition code is F(1), and the explanatory note says the transaction represents withholding of shares to satisfy tax withholding obligations upon vesting.
This filing is a routine insider tax-withholding sale rather than an open-market trade, and it was signed by Mr. Brown on 09/18/2025.